Skip to main content

Thanks to this community, Professor Kaylene Young and her multidisciplinary team are close to realising a ground-breaking new MS therapy.

A new therapy replacing myelin lost to MS is coming closer each day thanks to the generosity of people like you.

Such a treatment has the potential to protect and repair the brain and spinal cord, which is the greatest unmet need for people living with MS.

The treatment is being pioneered by a multidisciplinary team led by Professor Kaylene Young. It includes laboratory scientists, clinicians, biostatisticians, epidemiologists, geneticists – and importantly, MS advocates and people living with MS.

The goal is to identify the ‘signalling pathways’ that cause people to develop MS, and investigate how the disease impacts brain circuit function, to help create treatments that protect and even repair the brain.

The researchers are running a phase II clinical trial that would replace myelin in people with MS and evaluate the impact on their brain function.

Beyond this, they plan to study families with an unusually high incidence of MS in an effort to improve our understanding of the role genetics might play in cell behaviour.

This exciting research could pave the way for the next big breakthrough. Thanks for making it possible!

Get news and updates from MS Plus

Sign up